Multiple versus single doses of exogenous surfactant for the prevention or treatment of neonatal respiratory distress syndrome-Reference-Cited by-同舟云学术

Multiple versus single doses of exogenous surfactant for the prevention or treatment of neonatal respiratory distress syndrome

Published:2009-01-21 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Soll Roger¹,Özek Eren²

Affiliation:

1. University of Vermont; Division of Neonatal-Perinatal Medicine; Fletcher Allen Health Care, Smith 552A 111 Colchester Avenue Burlington Vermont USA 05401

2. Maramara University Medical Center; Pediatrics / Division of Neonatology; Maramara University Cemiltopuzlu cad. Güneþ apt.30/5 Çiftehavuzlar, Kadýköy Istanbul Turkey 3917

Publisher

Wiley

Subject

Pharmacology (medical)

Reference17 articles.

1. Double-blind randomized trial of one versus three prophylactic doses of synthetic surfactant in 826 neonates weighing 700 to 1000 grams: effects on mortality rate;Corbet;Journal of Pediatrics,1995

2. Single- vs multiple- dose surfactant replacement therapy in neonates of 30 to 36 weeks' gestation with respiratory distress syndrome;Dunn;Pediatrics,1990

3. Randomized European multicenter trial of surfactant replacement therapy for severe neonatal respiratory distress syndrome: single vs multiple doses of Curosurf;Speer;Pediatrics,1992

4. Factors associated with surfactant treatment response in infants with severe respiratory distress syndrome;Charon;Pediatrics,1989

5. Fujiwara T Konishi M Chida S Factors affecting response to a single postnatal dose of exogenous surfactant in surfactant treatment of lung disease Report of the 96th Ross Conference on Pediatric Research Ohio Ross Laboratories 1988

Cited by 82 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Risk factors for the time to development of retinopathy of prematurity in premature infants in Iran: a machine learning approach;BMC Ophthalmology;2024-08-23

2. Laryngeal mask airway surfactant administration for prevention of morbidity and mortality in preterm infants with or at risk of respiratory distress syndrome;Cochrane Database of Systematic Reviews;2024-01-25

3. Timing of surfactant treatment in respiratory distress syndrome;Seminars in Fetal and Neonatal Medicine;2023-12

4. The history of neonatal intubation;Seminars in Fetal and Neonatal Medicine;2023-10

5. Who Needs a Second Dose of Exogenous Surfactant?;The Journal of Pediatrics;2023-10